Search for: "Baker Norton Pharmaceuticals, Inc. "
Results 1 - 7
of 7
Sorted by Relevance
|
Sort by Date
12 Jan 2023, 12:00 am
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. [read post]
21 Aug 2024, 11:00 pm
Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. [read post]
5 Dec 2023, 1:30 am
“Much like the pharmaceutical companies being hammered by civil judgments and fines after enjoying years of profits from the sale of dangerous opioids, Smith & Wesson’s Board willfully ignores the potentially ruinous exposure the Company faces from its marketing and sale of weapons designed specifically for mass killing,” says Newman Ferrara partner Jeffrey Norton. [read post]
7 Mar 2012, 4:47 pm
A quick search reveals that this phrase had been previously used by Sir Robin in Leo Pharma A/S v Sandoz Ltd, [2009] EWCA Civ 1188 and before that in Bristol Myers Squibb Co v Baker Norton Pharmaceuticals Inc, [1999] RPC 253. [read post]
6 Jun 2013, 12:15 am
The doctrine of inherent anticipation (particularly after Schering Co. v Geneva Pharmaceuticals Inc. et Al., commented here - see also, in the UK, Merrell Dow v H N Norton & Co), may lead to similar distortions. [read post]
15 Jan 2015, 9:57 am
Southern Electronics Supply, Inc. v. [read post]
10 Jan 2008, 12:47 am
” Overseas sales of legal services by U.S. firms total about $5 billion a year, Norton said. [read post]
